HO-1 induction by HIF-1: A new mechanism for delayed cardioprotection?

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Dawn, Buddhadeb ^a   Bolli, Roberto ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR AGONIST; BILIRUBIN; BRADYKININ B2 RECEPTOR AGONIST; CYCLOOXYGENASE 2; DELTA OPIATE RECEPTOR AGONIST; DIMETHYLOXALYLGLYCINE; FERRITIN; GLYCINE DERIVATIVE; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; JANUS KINASE 1; JANUS KINASE 2; NITRIC OXIDE DONOR; PROTEIN KINASE C EPSILON; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

EDITORIAL; ENZYME MECHANISM; GENE EXPRESSION; GENE INDUCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART PROTECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOTONIC AGENTS; DNA-BINDING PROTEINS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MEMBRANE PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 23744449508     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00274.2005     Document Type: Editorial

References (23)

1. Baxter GF. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol 97: 268-275, 2002.
2. Belli R. The late phase of preconditioning. Circ Res 87: 972-983, 2000.
3. Boyle EM Jr, Kovacich JC, Hebert CA, Canty TG Jr, Chi E, Morgan EN, Pohlman TH, and Verrier ED. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg 116: 114-121, 1998.
4. Brahimi-Horn C, Mazure N, and Pouyssegur J. Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational modifications. Cell Signal 17: 1-9, 2005.
5. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, and Semenza GL. Means from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108: 79-85, 2003.
6. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, and Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Mean Circ Physiol 278: H643-H651, 2000.
7. Date T, Mochizuki S, Belanger AJ, Yamakawa M, Luo Z, Vincent KA, Cheng SH, Gregory RJ, and Jiang C. Expression of constitutively stable hybrid hypoxia-inducible factor-1α protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. Am J Physiol Cell Physiol 288: C314-C320, 2005.
8. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, Dawn B, Motterlini R, and Bolli R. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286: H1649-H1653, 2004.
9. Jung F, Palmer LA, Zhou N, and Johns RA. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 86: 319-325, 2000.
10. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, and Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342: 626-633, 2000.
11. Mateo J, Garcia-Lecea M, Cadenas S, Hernandez C, and Moncada S. Regulation of hypoxia-inducible factor-α by nitric oxide through mitochondria-dependent and -independent pathways. Biochem J 376: 537-544, 2003.
12. Mukaida N, Shiroo M, and Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 143: 1366-1371, 1989.
13. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, and Schomig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92: 748-755, 1995.
14. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA III, and Kukreja RC. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ Physiol 289: H542-H548, 2005.
15. Otterbein LE and Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279: L1029-L1037, 2000.
16. Qi X, Li J, Gu J, Li S, Dang Y, and Wang T. Plasma levels of IL-8 predict early complications in patients with coronary heart disease after percutaneous coronary intervention. Jpn Heart J 44: 451-461, 2003.
17. Riesenberg K, Levy R, Katz A, Galkop S, and Schlaeffer F. Neutrophil superoxide release and interleukiri 8 in acute myocardial infarction: distinction between complicated and uncomplicated states. Eur J Clin Invest 27: 398-404, 1997.
18. Ryter SW, Otterbein LE, Morse D, and Choi AM. Heme oxygenase/ carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234-235: 249-263, 2002.
19. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
20. Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, and Bolli R. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 38: 127-134, 2005.
21. Takahashi T, Sugishita Y, Nojiri T, Shimizu T, Yao A, Kinugawa K, Harada K, and Nagai R. Cloning of hypoxia-inducible factor 1α cDNA from chick embryonic ventricular myocytes. Biochem Biophys Res Commun 281: 1057-1062, 2001.
22. Yellon DM and Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83: 1113-1151, 2003.
23. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, and Perrella MA. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89: 168-173, 2001.